2020 Annual Meeting - Hypofractionation for Head and Neck Cancer
This course pulls together international experts in the use of hypofractionation for head and neck cancer, using a case based approach to illustrate common clinical scenarios. The impetus for this session is several-fold, including the high clinical relevance and well-recognized practice variability, coupled with the fact that the Annual Meeting theme is global health, and simultaneously a shift in the US towards an episode-based payment model, which incentivizes more efficient shorter course RT, when appropriate. As such we expect this panel will be very high yield for radiation oncologists, and will be quite lively. We have participants from the United States (Dr. Koyfman), the Christie Hospital in the United Kingdom (Dr. David Thomson), and Dr. Sandro Porceddu from University of Queensland in Australia. High yield and commonly encounters clinical scenarios will be addressed in a case-based format, which allows for audience input prior to consensus recommendations by our panelists. These cases are expected to include: (1) Palliative locally advanced case, especially for patients who are elderly, or travel from a distance, (2) an oligo-metastatic case, (3) recurrent unresectable disease in a previously radiated field, (4) hypo-fractionation regimens for skin cancer.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.
- Identify patients who may be appropriate for treatment with hypofractionated radiotherapy to the head and neck, and define acceptable schemes based on a variety of scenarios.
- Implement hypofractionation schemes for head and neck cancer into routine clinical care; specifically, the ability to define normal tissue constraints that need to be respected in different settings.
- John Nicholas Lukens, MD is employed at Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania and has no financial relationships with a commercial interest.
- David Thomson, MD is employed at Department of Clinical Oncology, The Christie NHS Foundation Trust and has no financial relationships with a commercial interest.
- Shlomo Koyfman, MD is employed at Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic and has research grants from Merck. Dr. Koyfman has investment interests from BristolMyersSquibb and Varian Medical Systems.
- Sandro Porceddu, MBBS, PhD is employed at Princess Alexandra Hospital and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
• No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
• No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
• ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.